According to the most recent financial data from March 2026, the current EPS (TTM) is $0.28. Cellebrite DI's EPS for 2025 came in at $0.32, marking an increase from -$1.35 in 2024. For the quarterly period ending on Mar 31, 2026, CLBT's EPS was $0.04.
Cellebrite DI had an annual EPS of $0.32, marking an increase of 123.7% from -$1.35 in 2024. The quarterly EPS for the period ending Mar 31, 2026, was $0.04, marking a 42.9% decrease from the same quarter last year. CLBT's TTM EPS stands at $0.28 as of March 2026. Cellebrite DI's EPS for 2024 stood at -$1.35, a 214% decrease from 2023.
Over the last 12 months, Cellebrite DI has registered an EPS growth of -42.9% (YoY, quarterly). Looking at a longer timeframe, the company recorded an average EPS growth rate of -20.6% per year over the past 3 years.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| CLBT Cellebrite DI Ltd | 51.04 | 123.7% | -20.6% | N/A |
| PHR Phreesia Inc | 64.6 | 103.9% | N/A | N/A |
| PHUN Phunware Inc | N/A | 39.4% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.